Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Current assets:                
Cash and cash equivalents $ 13,951,054     $ 27,265,703        
Other receivables     6,987        
Prepaid expenses and other current assets 2,572,033     434,699        
Total current assets 16,523,087     27,707,389        
Property and equipment, net 132,382     45,708        
Operating lease right-of-use assets 395,435     477,882        
Total assets 17,050,904     28,230,979        
Current liabilities:                
Accounts payable and accrued expenses 946,084     947,574        
Short-term notes payable 424,924     303,416        
Operating lease liabilities 201,973     194,270        
Total current liabilities 1,572,981     1,445,260        
Long-term liabilities:                
Operating lease liabilities 204,593     299,520        
Total long-term liabilities 204,593     299,520        
Shareholders’ equity:                
Preferred stock, no par value; 50,000,000 shares authorized; 5,417,000, and 9,417,000 Series A shares, 4,050,000 and 6,600,000 Series B shares, issued and outstanding at September 30, 2022 and December 31, 2021, respectively 1,592,723     2,656,713        
Common stock, $0.001 par value; 250,000,000 and 200,000,000 shares authorized at September 30, 2022 and December 31, 2021, respectively, 117,304,809 and 116,394,806 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 117,305     116,395        
Additional paid-in capital 196,888,079     194,987,219        
Accumulated deficit (183,324,777)     (171,274,128)        
Total shareholders’ equity 15,273,330 $ 18,674,898 $ 21,985,453 26,486,199 $ 28,546,423 $ 32,733,400 $ 36,050,467 $ 16,844,595
Total liabilities and shareholders’ equity $ 17,050,904     $ 28,230,979